Table 1. Demographic characteristics and comorbidities in patients with and without kidney transplantation.
| Kidney transplantation | Standard mean difference | ||
|---|---|---|---|
| No | Yes | ||
| (N = 5236) | (N = 5236) | ||
| Gender | |||
| Women | 2600(49.7) | 2468(47.1) | 0.05 |
| Men | 2636(50.3) | 2768(52.9) | 0.05 |
| Age stratified | |||
| ≤ 49 | 3692(70.5) | 3246(62.0) | 0.18 |
| 50–64 | 966(18.5) | 1802(34.4) | 0.37 |
| ≧65 | 578(11.0) | 188(3.59) | 0.29 |
| Age, mean±SD | 42.5±16.0 | 45.6±11.5 | 0.22 |
| Comorbidity | |||
| Alcohol-related illness | 128(2.44) | 110(2.10) | 0.02 |
| Gall stone | 76(1.45) | 133(2.54) | 0.08 |
| HCV | 46(0.88) | 295(5.63) | 0.27 |
| HBV | 177(3.38) | 450(8.59) | 0.22 |
| CMV | 0(0.00) | 9(0.17) | 0.06 |
| Polycystic kidney disease | 2(0.04) | 128(2.44) | 0.22 |
| Hyperlipidemia | 598(11.4) | 1667(31.8) | 0.51 |
| Diabetes | 255(4.87) | 743(14.2) | 0.32 |
| History of acute pancreatitis | 28(0.53) | 137(2.62) | <0.001 |
| Medications | |||
| Steroid | 978(18.7) | 209(3.99) | <0.001 |
| Tacrolimus | 2888(55.2) | ||
| Cyclosporin | 2545(48.6) | ||
| Sirolimus | 511(9.76) | ||
| Mycophenolatemofetil | 3591(65.6) | ||
| Certican | 3(0.06) | ||
| Thymoglobuline | 122(2.33) | ||